Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 99: 822-827, 2005. First published May 12, 2005; doi:10.1152/japplphysiol.00235.2005
8750-7587/05 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
99/3/822    most recent
00235.2005v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pattillo, R. E.
Right arrow Articles by Gladden, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pattillo, R. E.
Right arrow Articles by Gladden, L. B.

Red blood cell lactate transport in sickle disease and sickle cell trait

Robin E. Pattillo1 and L. Bruce Gladden2

1School of Nursing and 2Department of Health and Human Performance, Auburn University, Auburn, Alabama

Submitted 28 February 2005 ; accepted in final form 9 May 2005

This study determined and compared rates and mechanisms of lactate transport in red blood cells (RBCs) of persons with 1) sickle cell disease (HbSS), 2) sickle cell trait (HbAS), and 3) a control group (HbAA). Blood samples were drawn from 30 African-American volunteers (10 HbSS, 10 HbAS, 10 HbAA). Lactate influx into RBCs was measured by using [14C]lactate at six (2, 5, 10, 15, 25, and 40 mM) unlabeled lactate concentrations. The monocarboxylate transporter pathway was blocked by p-chloromercuriphenylsulfonic acid to determine its percent contribution to total lactate influx. Generally, total lactate influx into RBCs from the HbSS group was significantly greater than influx into RBCs from HbAS or HbAA, with no difference between HbAS and HbAA. Faster influx into HbSS RBCs was attributed to increased monocarboxylate transporter activity [increased apparent Vmax (V'max)]. V'max (4.7 ± 0.6 µmol·ml–1·min–1) for HbSS RBCs was significantly greater than V'max of HbAS RBCs (2.9 ± 1.5 µmol·ml–1·min–1) and HbAA RBCs (2.0 ± 0.5 µmol·ml–1·min–1). Km (42.8 ± 8 mM) for HbSS RBCs was significantly greater than Km (27 ± 12 mM) for HbAA RBCs. We suspect that elevated erythropoietin levels in response to chronic anemia and/or pharmacological treatment (erythropoietin injections, hydroxyurea ingestion) is the underlying mechanism for increased lactate transport capacity in HbSS RBCs.

monocarboxylate transport; lactate influx; Michaelis-Menten kinetics



Address for reprint requests and other correspondence: L. B. Gladden, Dept. of Health and Human Performance, Auburn Univ., 2050 Memorial Coliseum, Auburn, AL 36849–5323 (E-mail: gladdlb{at}auburn.edu)




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
S. Fagnete, C. Philippe, H. Olivier, M.-H. Mona, E.-J. Maryse, and H.-D. Marie-Dominique
Faster lactate transport across red blood cell membrane in sickle cell trait carriers
J Appl Physiol, February 1, 2006; 100(2): 427 - 432.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.